2 July 2013 - Deborah Wilkes
Archived
AstraZeneca's proton-pump inhibitor esomeprazole will soon gain non-prescription status throughout the European Union, and will be launched as Nexium Control by Pfizer Consumer Healthcare from the "second quarter of 2014 onwards".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.